We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current VETOF market cap is 659.8M. The company's latest EPS is EUR 4.6760 and P/E is 21.64.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 401.36M | 432.96M | 531.61M | 545.73M | 542.01M |
| Operating Income | 41.94M | 38.73M | 86.28M | 75.4M | 77.7M |
| Net Income | 28.59M | 19.22M | 62.86M | 48M | 55.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 511.47M | 646.09M | 624.56M | 651.85M | 692.23M |
| Total Liabilities | 125.49M | 274.26M | 183.21M | 167.19M | 165.12M |
| Total Equity | 385.98M | 371.83M | 441.35M | 484.66M | 527.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 52.02M | 92.23M | 89.72M | 62.86M | 89.39M |
| Investing | -64.55M | -145.14M | -33.45M | -21.52M | -18.88M |
| Financing | -20.12M | 101.99M | -120.85M | -16.06M | -15.5M |
| Market Cap | 659.8M |
| Price to Earnings Ratio | 21.64 |
| Price to Sales Ratio | 2.22 |
| Price to Cash Ratio | 8.15 |
| Price to Book Ratio | 2.28 |
| Dividend Yield | - |
| Shares Outstanding | 11.88M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 80.91k (100%) |
| Company Name | Vetoquinol (PK) |
| Address |
34 rue du chene sainte anne magny-vernois lure 70200 |
| Website | https://www.vetoquinol.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
